SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-23-017837
Filing Date
2023-03-06
Accepted
2023-03-06 17:01:43
Documents
94
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2022_oramedpharma.htm   iXBRL 10-K 1659227
2 DESCRIPTION OF SECURITIES f10k2022ex4-4_oramedpharma.htm EX-4.4 13015
3 CONSULTING AGREEMENT BY AND BETWEEN ORAMED PHARMACEUTICALS INC. AND SHNIDA LTD., f10k2022ex10-1_oramedpharma.htm EX-10.1 75878
4 EMPLOYMENT AGREEMENT BY AND BETWEEN ORAMED LTD. AND NADAV KIDRON, ENTERED INTO A f10k2022ex10-2_oramedpharma.htm EX-10.2 125478
5 SECOND AMENDMENT, DATED OCTOBER 25, 2022, TO EMPLOYMENT AGREEMENT, BY AND BETWEE f10k2022ex10-13_oramedpharma.htm EX-10.13 6120
6 REPRESENTATIVE FORM OF INDEMNIFICATION AGREEMENTS BETWEEN ORAMED PHARMACEUTICALS f10k2022ex10-14_oramedpharma.htm EX-10.14 86240
7 FORM OF RESTRICTED STOCK UNIT NOTICE AND RESTRICTED STOCK UNIT AGREEMENT f10k2022ex10-23_oramedpharma.htm EX-10.23 38114
8 ORAVAX MEDICAL, INC. 2021 LONG-TERM INCENTIVE PLAN f10k2022ex10-41_oramedpharma.htm EX-10.41 226531
9 ORAVAX STOCK OPTION AGREEMENT f10k2022ex10-42_oramedpharma.htm EX-10.42 48298
10 CONSENT OF KESSELMAN & KESSELMAN, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM f10k2022ex23-1_oramedpharma.htm EX-23.1 2458
11 CERTIFICATION f10k2022ex31-1_oramedpharma.htm EX-31.1 10587
12 CERTIFICATION f10k2022ex31-2_oramedpharma.htm EX-31.2 10347
13 CERTIFICATION f10k2022ex32-1_oramedpharma.htm EX-32.1 3934
14 CERTIFICATION f10k2022ex32-2_oramedpharma.htm EX-32.2 3672
15 GRAPHIC fin_001.jpg GRAPHIC 2125
16 GRAPHIC ex10-2_001.jpg GRAPHIC 319111
17 GRAPHIC ex23-1_001.jpg GRAPHIC 2276
  Complete submission text file 0001213900-23-017837.txt   9022584

Data Files

Seq Description Document Type Size
18 XBRL SCHEMA FILE ormp-20221231.xsd EX-101.SCH 94484
19 XBRL CALCULATION FILE ormp-20221231_cal.xml EX-101.CAL 41120
20 XBRL DEFINITION FILE ormp-20221231_def.xml EX-101.DEF 359246
21 XBRL LABEL FILE ormp-20221231_lab.xml EX-101.LAB 725005
22 XBRL PRESENTATION FILE ormp-20221231_pre.xml EX-101.PRE 375508
88 EXTRACTED XBRL INSTANCE DOCUMENT f10k2022_oramedpharma_htm.xml XML 1004090
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35813 | Film No.: 23709740
SIC: 2834 Pharmaceutical Preparations